Lesion of the sciatic nerve caused a rapid increase in c-fos and c-jun mRNA that was followed about 2 hr later by an increase in nerve growth factor (NGF) mRNA. To evaluate whether the initial increase in c-fos mRNA is causally related to the subsequent increase in NGF mRNA, we performed experiments with fibroblasts of transgenic mice carrying an exogenous c-fos gene under the control of a metallothionein promoter. In primary cultures of these fibroblasts, CdCI2 evoked a rapid increase in exogenous c-fos mRNA, followed immediately by an increase in endogenous c-jun mRNA and with a slight delay by an increase in NGF mRNA. In fibroblasts of C3H control mice, CdCI2 had no effect on the mRNA levels of the protooncogenes c-fos and c-jun or of NGF. Additional 
The protooncogene c-fos belongs to a family ofgenes that are rapidly and transiently activated by a great variety of stimuli such as growth factors, ionophores, and phorbol esters (1) (2) (3) (4) (5) . The c-fos mRNA encodes the nuclear protein Fos, which is an intermediate in the signal transduction of external stimuli to the nucleus (6) . It has been suggested that c-fos plays an essential role in cellular growth (3, 7) and differentiation (6, 8, 9) . It has been shown that c-fos is involved in the transactivation of several genes (6, (10) (11) (12) (13) (14) (15) . Fos is known to associate with DNA in a complex with other proteins, initially termed p39 (16) , one of which is Jun/AP-1 (17) (18) (19) .
The association of Fos and Jun in the heterodimeric complex (transcription factor AP-1) is mediated by regularly spaced leucine residues (20) and is required for functional activity (6, 19) , apparently by binding to a specific recognition site in the promoter region of the corresponding genes (19, 21, 22) .
We previously showed (23, 24) that transection of the sciatic nerve led to an enhanced synthesis of nerve growth factor (NGF) by the non-neuronal cells surrounding the axons. The rapid increase in NGF mRNA reached a maximum by 12 hr after lesion. Here we report that transection of the sciatic nerve also leads to an induction of c-fos and c-jun mRNA that precedes the increase in NGF mRNA in the injured nerve. To determine whether the lesion-mediated increases in c-fos and c-jun mRNAs were (24) .
Cell Culture and Transfection. Fibroblasts prepared from the skin of-normal and transgenic mice by sequential collagenase (0.1%, 15 min) and trypsin (0.1%, 15 min) digestions (26) were cultured in DMEM with 10% FBS. Confluent cultures were stimulated with CdC12 (10 MM), after which total cellular RNA was prepared. For transfection experiments the fibroblasts were replated (2 x 105 cells per 60-mm dish) in DMEM with 5% FBS. After 2 days the cells were transfected for 14 hr with 6 Ag of the NGF promoter-CAT reporter plasmid or 6 Aug of the MT-c-fos-LTR expression plasmid plus 2 1Lg of the NGF promoter-CAT reporter plasmid by a modified calcium phosphate precipitation method (27) . After washing, the cells were incubated in DMEM containing 0.5% FBS in the presence or absence of 5 IuM CdC12 for 36 hr. The cells were harvested and equal Abbreviations: NGF, nerve growth factor; CAT, chloramphenicol acetyltransferase; MT, metallothionein; LTR, long terminal repeat. §The sequence ofthe NGF promoter region reported in this paper has been deposited in the GenBank data base (accession no. M33683).
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amounts of cell extract protein were assayed for CAT activity as described (28) .
RNA Analyses. Total RNA was prepared (24, 26) and separated according to size in a 1.2% agarose gel. For measuring the efficiencies of RNA preparations, 20 pg of NGF recovery standard (a 510-nucleotide in vitro transcript in sense orientation) was added to each sample prior to extraction. Following vacuum blotting the nylon filters (Hybond N, Amersham) were hybridized with mouse c-fos and mouse NGF complementary RNA probes as described (26) . The filters were then washed, treated with RNase A (0.1 ,ug/ml), and exposed to Fuji RX film. The c-fos-and NGFspecific transcripts were quantified by densitometric scanning of the autoradiograms.
DNA Construction and Site-Directed Mutagenesis. A 2.1-kilobase HincII-Pvu II fragment of the NGF promoter region was inserted between the Xba I and Xho I sites of the CAT expression vector pBLCAT3 (29) to produce pPNCAT. To obtain the deletion fragments, the promoter region was cut with restriction enzyme (EcoNI or Hae II), and the resulting fragments were again linked to the CAT reporter plasmid. To introduce the point mutation of the intronic AP-1 site in the construct pPN-58CAT, an oligodeoxynucleotide (AGCG-CATCGGAITAGTCAGGCTT) was extended by the polymerase chain reaction (30) to give plasmid pPN-58mACAT.
Preparation of Nuclear Extracts and DNase I Footprint Analysis. Skin fibroblasts oftransgenic mice were prepared as described above, grown in DMEM with 5% FBS until they reached 90%o confluency, and stimulated with 10 ,uM CdCl2 for 8 hr. For control extracts, confluent NIH 3T3 fibroblasts were kept in DMEM with 0.5% FBS for 2 days before they were harvested. Nuclear extracts were prepared as described (31) .
A 970-base-pair Bgl II fragment spanning the 5' promoter region, exon lb, and the AP-1 binding site was cloned into the multiple cloning site of a Bluescript SK(-) vector (Stratagene). EcoRI was used to label the fragment at either side by filling in with Klenow DNA polymerase, and two other restriction sites were used to remove the fragment from the vector. One to two nanograms of end-labeled fragment was treated with DNase I (Pharmacia) as described (32) .
RESULTS
Lesion-Mediated Changes in mRNA Levels of c-fos, c-jun, and NGF. For reasons of convenience we performed the experiments with sciatic nerve pieces in culture, as it had been shown that the initial time course of NGF mRNA changes was virtually the same in vivo after nerve lesion and in vitro (24) . As shown in Fig. 1 A and B, NGF mRNA began to increase after 2 hr in culture, attaining a maximal level by 12 hr of incubation. In contrast, c-fos mRNA was already significantly increased after 30 min and reached a peak by 2 hr. The time course of c-jun mRNA changes was very similar to that of c-fos, peaking also by 2 hr (Fig. 1 B and C) .
Cycloheximide (5 ,g/ml), an inhibitor of protein synthesis, partially blocked the increase in NGF mRNA (data not shown). Under the same conditions c-fos mRNA was superinduced, in agreement with previous studies (3, 33) .
CdCl2 Induces an Increase in NGF mRNA in Transgenic Fibroblasts. To evaluate whether the increase in c-fos mRNA was causally related to NGF expression, we used fibroblasts of transgenic mice carrying an exogenous c-fos gene controlled by a human MT promoter (MT-c-fos-LTR). The 3' nontranslated region of the mouse c-fos mRNA, which is responsible for its instability, is replaced in this construct by a retroviral LTR to assure a sustained high level of c-fos expression (construct p76/21; ref. 25) . As shown by Ruther et al. (25) administration of CdCl2 to these mice leads to >10-fold increase in c-fos mRNA in most tissues tested. In view of the high toxicity of CdCl2 in vivo, we refrained from in vivo experiments. Since previous studies had shown that primary cultures offibroblasts are a good system to study the regulation of NGF expression (26) , we prepared fibroblast cultures from the MT-c-fos-LTR transgenic mice and corresponding control mice. Addition of 10 ,uM CdCl2 to the transgenic fibroblast cultures resulted in a time-dependent increase in exogenous c-fos mRNA ( Fig. 2A) , accompanied by a virtually simultaneous increase in endogenous c-jun mRNA (Fig. 2B ) and followed with some delay by an increase in NGF mRNA ( Fig. 2A) . In fibroblasts from control C3H mice the mRNA levels of c-fos and NGF were not significantly changed after the addition of CdCI2, excluding the possibility that CdCl2 had additional, nonspecific effects ( Fig.   2A Inset) the NGF promoter-CAT reporter plasmid pPNCAT and tested for CAT activity before and after CdCl2 treatment. CdCl2 increased the activity of pPNCAT about 6-fold in the transgenic fibroblasts (Fig. 3) .
Fos Binding to the NGF Promoter. Several genes that are regulated by Fos share a motif similar to the AP-1 consensus sequence S'-TGAGTCA-3'. Analysis of the sequence of the NGF promoter fragment used in the transfection studies revealed nine sequences resembling the AP-1 consensus sequence (see Fig. SA ). To evaluate whether a transcription factor(s) binds to all or part of these AP-1-like sequences in the NGF promoter region, we performed in vitro DNase I footprint experiments. Comparing the footprint patterns obtained with nuclear extracts from quiescent 3T3 fibroblasts and from CdCl2-stimulated skin fibroblasts prepared from MT-c-fos-LTR transgenic mice, we found that c-fos induction resulted in only one additional protected site in the NGF promoter region between positions -1000 and +289. The region protected from DNase I, positions +33 to +50, contained the AP-1 consensus sequence TGAGTCA ( 4A). None of the other sites resembling the AP-1 consensus sequence was protected from DNase I digestion in these experiments (Fig. 4B) .
Functional Activity of the Intronic AP-1 Site. The functional importance of this intronic AP-1 binding site for the regulation of the NGF promoter by c-fos was evaluated by cotransfection of fibroblasts with the MT-c-fos-LTR expression vector and various promoter-deletion mutants of the NGF promoter-CAT reporter plasmid (Fig. SB) . The construct pPNCAT contained a 2.1-kilobase fragment including the transcription initiation site and comprising both CAAT-box and TATA-box consensus sequences as well as 250 base pairs of the first intron, including the AP-1 binding site at position +35. Upon stimulation of the exogenous c-fos gene by the addition of CdCl2 to the cotransfected cells, the transcriptional activity of the NGF promoter increased about 6-fold (Fig. 5C ). Deleting the sequences 3' to position +4 (pPN+4CAT) reduced the basal activity of the NGF promoter about 10-fold (data not shown) and eliminated its inducibility by c-fos; deleting the sequences 5' to position -58 (pPN-58CAT) also reduced the basal activity of the remaining fragment, which included the two TATA-box consensus sequences and the AP-1 binding site, by a factor of about 30 (data not shown). In contrast to pPN+4CAT this construct still retained its inducibility by c-fos. To prove the functional role of the intronic AP-1 site, a point mutation changing the AP-1 binding sequence from TGAGTCA to ATAGTCA was introduced into pPN-58CAT. This mutant construct (pPN-58mACAT) lost its c-fos-inducibility and showed a decreased basal activity. Thus, the transcriptional regulation of NGF by c-fos is mediated by this AP-1 site located in the first intron of the NGF gene. Moreover, the intronic AP-1 site seems also to contribute to the basal NGF DISCUSSION Our results provide evidence that the NGF gene is a target for c-fos activity. This conclusion is based upon the finding that selectively induced c-fos regulates NGF promoter activity. In primary cultures of skin fibroblasts of MT-c-fos-LTR transgenic mice, CdCl2 treatment led to an increase in exogenous c-fos mRNA followed immediately by an increase in c-jun mRNA and with a slight delay by an increase in NGF mRNA. In control experiments with normal mouse fibroblasts, CdCl2 did not affect the level of c-fos mRNA or NGF mRNA. This indicates that the observed induction of NGF mRNA was due to an activation of the MT promoter of the exogenous c-fos rather than to a nonspecific effect of CdCl2. Moreover, CdCl2 treatment induced CAT activity in normal C3H mouse fibroblasts that had been cotransfected with the NGF promoter-CAT reporter plasmid pPNCAT and the MT-c-fos-LTR expression plasmid, indicating that Fos can interact with the promoter region of the NGF gene (Fig. 5C) . Our results support the assumption that the level of Jun protein does not represent a limiting factor under our experimental conditions. This might be due to either a sufficiently high steady-state level of Jun (36) or a c-fos-induced positive regulation of transcription of the c-jun protooncogene by its own product (37) . Indeed, the addition of CdCl2 to cultured fibroblasts of transgenic mice led not only to an increased level of exogenous c-fos mRNA but also to an increase in endogenous c-jun mRNA (Fig. 2B) .
To identify AP-1-responsive elements in the NGF gene, DNase I footprint assays were performed. We looked for differences in the protection pattern of the NGF promoter region, comparing nuclear extract of quiescent 3T3 fibroblasts with that of MT-c-fos-LTR transgenic fibroblasts expressing high levels of Fos. No specifically induced footprints were observed 1000 bases upstream of the transcription start site: in both cases a factor(s) bound to the TATA box (data not shown) but the sequences resembling the AP-1 consensus sequence were not protected (see Fig. 4B ). The only major difference in the footprint patterns was that the extract from the c-fos-expressing cells afforded a strong protection from DNase I digestion in a region (positions +33 to +50) centered around an AP-1 consensus sequence and directly adjacent to the exon lb/intron border. These results indicate the presence of an AP-1 binding site in the first intron. The AP-1 binding sites of the collagen and transin genes are located at almost identical positions around -70. However, this position relative to the transcription start site does not seem to be mandatory to make an AP-1 binding site functional (32) . For example, an enhancer element in the first intron of the 4F2 heavy-chain gene contains an AP-1 site that is necessary for full enhancer activity (38) . The absence of AP-1 binding to the AP-1-like sequences in the NGF promoter region is in accordance with the findings of Risse et al. (39) , who determined the capacity of systematically point- (40) . The transactivating function of a DNAbound factor can additionally be regulated by posttranslational modifications as in the case of the serum response factor (41) .
To test the regulatory function of the intronic AP-1 binding site on NGF promoter activity, primary cultures of skin fibroblasts were cotransfected with a c-fos expression vector and CAT reporter constructs containing various fragments of the NGF promoter. The c-fos inducibility of the construct pPNCAT was lost in a similar construct that lacked only the sequence 3' to position +4. In contrast, deleting the promoter sequences 5' to position -58 did not eliminate the inducibility by c-fos. However, the mutation of the intronic AP-1 site in this construct resulted in a loss of c-fos responsiveness.
These results demonstrate that the AP-1 complex not only binds to the sequence around position +35 but also has a positive regulatory function on the NGF promoter activity.
Deleting or mutating the intronic AP-1 site not only eliminated the inducibility of the NGF promoter by c-fos but also reduced the basal NGF promoter activity. This implies that AP-1 may also be involved in the regulation of the basal activity ofthe NGF promoter, but it has to be considered that the NGF promoter activity we define here as "basal" activity might reflect an already elevated activity of the NGF promoter. In pieces of the sciatic nerve kept in culture for 3 days the NGF mRNA level was about 8-fold higher than that in intact nerve (23) . Thus, the fibroblasts used in the transfection experiments may have been in a similar activated state with an enhanced NGF mRNA expression. Consistent with this interpretation is the observation that in the transfection experiments with the pPNCAT vector, the NGF promoter activity was higher than that of other promoters (e.g., the thymidine kinase promoter; data not shown). This could also explain why the inducibility of the NGF promoter-CAT reporter construct was less pronounced (about 6-fold) than the observed increase in NGF mRNA when pieces of sciatic nerve were brought into culture (about 45-fold) (24) .
We have provided evidence for a role of c-fos in the regulation of NGF expression under various experimental in vitro conditions. These results suggest that similar mechanisms might activate NGF expression in vivo. Transection of a peripheral nerve, like induction by serum (1), is followed by a rapid and transient increase in c-fos mRNA. The subsequent induction of NGF mRNA outlasts the typical short c-fos peak (Fig. 1B) and results in a local synthesis of NGF protein in the non-neuronal cells surrounding the axon (23).
The nerve lesion coinduces c-fos and c-jun, which is a prerequisite for the formation of the biologically active AP-1 complex (19) . These observations indicate that c-fos could also regulate NGF induction after sciatic nerve lesion in vivo.
The nature of the signal that leads to the initial induction of c-fos remains to be identified; however, in long-term sciatic nerve cultures interleukin 1 seems to be the responsible agent regulating NGF mRNA levels (42) .
In support of our data are the results presented by Moccetti et al. (43) . They demonstrated an increase in c-fos mRNA followed by increased NGF mRNA levels afterf-adrenergic stimulation of C6-2B astrocytoma cells. 
